Protein tyrosine kinases: their roles and their targeting in leukemia

K K. Bhanumathy, A Balagopal, FS Vizeacoumar… - Cancers, 2021 - mdpi.com
Simple Summary Protein phosphorylation is a key regulatory mechanism that controls a
wide variety of cellular responses. This process is catalysed by the members of the protein …

Human and mouse early B cell development: So similar but so different

J Korzhenevich, I Janowska, M van der Burg, M Rizzi - Immunology Letters, 2023 - Elsevier
Early B cell development in the bone marrow ensures the replenishment of the peripheral B
cell pool. Immature B cells continuously develop from hematopoietic stem cells, in a process …

The structural effect of FLT3 mutations at 835th position and their interaction with acute myeloid leukemia inhibitors: in silico approach

AM Al-Subaie, B Kamaraj - International journal of molecular sciences, 2021 - mdpi.com
FMS-like tyrosine kinase 3 (FLT3) gene mutations have been found in more than one-third of
Acute Myeloid Leukemia (AML) cases. The most common point mutation in FLT3 occurs at …

Targeting proliferation signals and the cell cycle machinery in acute leukemias: novel molecules on the horizon

A Ghelli Luserna di Rorà, M Jandoubi, G Martinelli… - Molecules, 2023 - mdpi.com
Uncontrolled proliferative signals and cell cycle dysregulation due to genomic or functional
alterations are important drivers of the expansion of undifferentiated blast cells in acute …

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia

SS Ge, SB Liu, SL Xue - Frontiers in Oncology, 2022 - frontiersin.org
FLT3 mutations are one of the most common genetic alterations in acute myeloid leukemia
(AML) and are identified in approximately one-third of newly diagnosed patients. Aberrant …

Mutation spectrum of FLT3 and significance of non‐canonical FLT3 mutations in haematological malignancy

SS Ge, QC Qiu, HP Dai, XD Shen… - British Journal of …, 2023 - Wiley Online Library
Fms‐like tyrosine kinase 3 (FLT3) is frequently mutated in haematological malignancies.
Although canonical FLT3 mutations including internal tandem duplications (ITDs) and …

Targeting leukemia-initiating cells in acute lymphoblastic leukemia

F Tamiro, AP Weng, V Giambra - Cancer Research, 2021 - AACR
The concept that different leukemias are developmentally distinct and, like in normal
hematopoiesis, generated by restricted populations of cells named leukemia-initiating cells …

[HTML][HTML] Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance

FM Uckun, S Qazi - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Aim: The main goal of this study was to elucidate at the transcript level the tyrosine kinase
expression profiles of primary leukemia cells from mixed lineage leukemia 1 gene …

Profiling FLT3 Mutations in Mexican Acute Myeloid Leukemia Pediatric Patients: Impact on Overall Survival

C Molina Garay, K Carrillo Sánchez… - Frontiers in …, 2020 - frontiersin.org
Background: Acute myeloid leukemia (AML) is the second most frequent leukemia in
childhood. The FLT3 gene participates in hematopoietic stem cell proliferation. FLT3 …

FLT3-ITD and CD135 over-expression are frequent findings of poor survival in adult patients with acute leukemias

J Vela-Ojeda, PV Cardenas, MAGR Esparza… - Archives of Medical …, 2021 - Elsevier
Background Fms-like tyrosine kinase 3 (FLT3) expression and mutation have been
considered a poor prognostic factor in acute myeloid leukemia (AML). FLT3-ITD mutation is …